Ke Ren Selected Research

Long Noncoding RNA

1/2023	GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis.
1/2021	TP53-Activated lncRNA GHRLOS Regulates Cell Proliferation, Invasion, and Apoptosis of Non-Small Cell Lung Cancer by Modulating the miR-346/APC Axis.
1/2021	Long Non-Coding RNA MDFIC-7 Promotes Chordoma Progression Through Modulating the miR-525-5p/ARF6 Axis.
1/2019	LncRNA AFAP1-AS1 Supresses miR-139-5p and Promotes Cell Proliferation and Chemotherapy Resistance of Non-small Cell Lung Cancer by Competitively Upregulating RRM2.
1/2019	Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ke Ren Research Topics

Disease

52	Pain (Aches) 01/2024 - 02/2002
47	Inflammation (Inflammations) 12/2023 - 02/2002
47	Hyperalgesia 01/2019 - 02/2002
31	Neoplasms (Cancer) 01/2024 - 11/2005
14	Infections 01/2023 - 11/2013
8	Hypersensitivity (Allergy) 01/2018 - 10/2008
7	Neuralgia (Stump Neuralgia) 02/2014 - 10/2008
6	Hypoxia (Hypoxemia) 01/2021 - 11/2015
6	Acute Kidney Injury (Acute Renal Failure) 10/2020 - 01/2014
5	Facial Pain (Myofacial Pain) 01/2023 - 12/2009
5	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 05/2009
5	Osteosarcoma (Osteogenic Sarcoma) 02/2021 - 10/2014
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 10/2015
4	Carcinogenesis 01/2019 - 05/2009
4	Chronic Pain 01/2015 - 10/2008
4	Prion Diseases (Transmissible Spongiform Encephalopathies) 12/2014 - 03/2013
4	Osteolysis 08/2014 - 08/2011
4	Scrapie 06/2014 - 03/2013
4	Edema (Dropsy) 05/2008 - 08/2004
3	Sepsis (Septicemia) 01/2024 - 02/2021
3	Breast Neoplasms (Breast Cancer) 01/2023 - 02/2014
3	Lung Injury 01/2023 - 01/2016
3	Carcinoma (Carcinomatosis) 09/2022 - 09/2013
3	Osteoarthritis 08/2022 - 01/2011
3	Arthralgia (Joint Pain) 08/2022 - 01/2006
3	Neoplasm Metastasis (Metastasis) 01/2018 - 10/2014
3	Acute Pain 01/2015 - 01/2009
3	Alzheimer Disease (Alzheimer's Disease) 04/2014 - 01/2005
3	Arthritis (Polyarthritis) 01/2014 - 01/2006
3	Bone Neoplasms (Bone Cancer) 10/2008 - 11/2005
2	Acute Lung Injury 01/2024 - 01/2023
2	Bites and Stings (Sting) 12/2023 - 01/2019
2	Communicable Diseases (Infectious Diseases) 10/2023 - 01/2023
2	Hemorrhage 01/2023 - 06/2012
2	Schizophrenia (Dementia Praecox) 12/2022 - 04/2008
2	Wounds and Injuries (Trauma) 11/2022 - 02/2010
2	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022 - 06/2012
2	Hypertension (High Blood Pressure) 06/2021 - 02/2019
2	Body Weight (Weight, Body) 01/2019 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 11/2005
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 09/2014

Drug/Important Bio-Agent (IBA)

32	Freund's AdjuvantIBA 02/2013 - 05/2002
21	Proteins (Proteins, Gene)FDA Link 11/2022 - 07/2003
12	CytokinesIBA 11/2022 - 07/2005
10	Messenger RNA (mRNA)IBA 10/2023 - 10/2002
10	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2013 - 02/2002
9	Serotonin (5 Hydroxytryptamine)IBA 06/2014 - 09/2005
7	PrionsIBA 01/2016 - 11/2013
6	Small Interfering RNA (siRNA)IBA 01/2019 - 06/2010
6	Opioid Receptors (Opioid Receptor)IBA 01/2018 - 09/2004
5	Long Noncoding RNAIBA 01/2023 - 01/2019
5	Analgesics (Analgesic Drugs)IBA 01/2023 - 05/2002
5	IodineIBA 11/2019 - 09/2014
5	hydroxypropyl methacrylateIBA 01/2016 - 08/2011
5	Opioid Analgesics (Opioids)IBA 03/2014 - 09/2004
5	N-Methylaspartate (NMDA)IBA 02/2013 - 02/2002
5	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2012 - 05/2007
5	salicylhydroxamic acid (SHAM)IBA 09/2011 - 09/2004
5	Interleukin-1beta (Interleukin 1 beta)IBA 04/2009 - 03/2007
4	Contrast MediaIBA 02/2024 - 08/2011
4	Capsaicin (Zostrix)FDA Link 01/2024 - 02/2006
4	Biomarkers (Surrogate Marker)IBA 03/2023 - 01/2019
4	AcidsIBA 01/2021 - 10/2002
4	ChemokinesIBA 01/2021 - 04/2012
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016 - 08/2011
4	ProdrugsIBA 01/2016 - 02/2014
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2011 - 01/2006
3	CreatinineIBA 06/2021 - 01/2019
3	Focal Adhesion Protein-Tyrosine KinasesIBA 02/2021 - 10/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 03/2017
3	Local AnestheticsIBA 01/2019 - 07/2002
3	Indicators and Reagents (Reagents)IBA 01/2018 - 10/2015
3	PrPSc ProteinsIBA 01/2016 - 11/2013
3	SolutionsIBA 12/2015 - 11/2005
3	Narcotic Antagonists (Opioid Antagonists)IBA 09/2011 - 09/2005
3	Neurotransmitter Agents (Neurotransmitter)IBA 11/2010 - 05/2007
3	Glutamate Receptors (Glutamate Receptor)IBA 10/2008 - 02/2002
3	methanesulfonate salt 2-hydroxy-4,4'-diamidinostilbeneIBA 12/2005 - 10/2003
3	AMPA Receptors (AMPA Receptor)IBA 08/2004 - 02/2002
3	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 07/2003 - 02/2002
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 01/2016
2	MicroRNAs (MicroRNA)IBA 01/2023 - 02/2019
2	UbiquitinIBA 01/2023 - 06/2014
2	3' Untranslated Regions (3' UTR)IBA 01/2023 - 01/2021
2	Hyaluronic Acid (Hyaluronan)IBA 08/2022 - 09/2020
2	iodixanol (Visipaque)FDA Link 10/2020 - 01/2018
2	Peptides (Polypeptides)IBA 01/2020 - 01/2005
2	NF-kappa B (NF-kB)IBA 01/2018 - 06/2010

Therapy/Procedure

19	Electroacupuncture 02/2014 - 08/2004
14	Therapeutics 01/2023 - 08/2010
4	Drug Therapy (Chemotherapy) 01/2019 - 09/2011
4	Spinal Injections 06/2014 - 11/2007
4	Acupuncture Points (Acupuncture Point) 10/2008 - 09/2004
3	Analgesia 01/2023 - 05/2002
3	Microspheres (Microsphere) 01/2021 - 12/2015
3	Injections 11/2020 - 09/2005
3	Ligation 01/2019 - 07/2010
2	Neoadjuvant Therapy 01/2023 - 01/2018
2	Pain Management 01/2023 - 05/2005
2	Intra-Articular Injections 09/2020 - 01/2011